metformin has been researched along with Encapsulating Peritoneal Sclerosis in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J | 1 |
| Li, J | 1 |
| Feng, B | 1 |
| Bi, Z | 1 |
| Zhu, G | 1 |
| Zhang, Y | 1 |
| Li, X | 1 |
| Shin, HS | 1 |
| Ko, J | 1 |
| Kim, DA | 1 |
| Ryu, ES | 1 |
| Ryu, HM | 1 |
| Park, SH | 1 |
| Kim, YL | 1 |
| Oh, ES | 1 |
| Kang, DH | 1 |
2 other studies available for metformin and Encapsulating Peritoneal Sclerosis
| Article | Year |
|---|---|
Activation of AMPK-PGC-1α pathway ameliorates peritoneal dialysis related peritoneal fibrosis in mice by enhancing mitochondrial biogenesis.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; DNA, Mitochondrial; Metformin; Mice | 2022 |
Metformin ameliorates the Phenotype Transition of Peritoneal Mesothelial Cells and Peritoneal Fibrosis via a modulation of Oxidative Stress.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Cells, Cultured; Disease Models, Animal; Epithelial-M | 2017 |